Search Results - Marcomigni, Luca

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Alectinib’s activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series

    Alectinib’s activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series by Metro, Giulio, Lunardi, Gianluigi, Bennati, Chiara, Chiarini, Pietro, Sperduti, Isabella, Ricciuti, Biagio, Marcomigni, Luca, Costa, Cinzia, Crinò, Lucio, Floridi, Piero, Gori, Stefania, Chiari, Rita

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer

    Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer by Metro, Giulio, Gariazzo, Eleonora, Costabile, Silvia, Baglivo, Sara, Roila, Fausto, Colamartini, Francesca, Palumbo, Barbara, Chiarini, Pietro, Gori, Stefania, Conti, Antonio, Marcomigni, Luca, Bellezza, Guido, Lunardi, Gianluigi

    Published in Oncology and therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer

    Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer by Metro, Giulio, Gariazzo, Eleonora, Costabile, Silvia, Baglivo, Sara, Roila, Fausto, Colamartini, Francesca, Palumbo, Barbara, Chiarini, Pietro, Gori, Stefania, Conti, Antonio, Marcomigni, Luca, Bellezza, Guido, Lunardi, Gianluigi

    Published in Oncology and therapy
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Multiple EWSR1-WT1 and WT1-EWSR1 copies in two cases of desmoplastic round cell tumor

    Multiple EWSR1-WT1 and WT1-EWSR1 copies in two cases of desmoplastic round cell tumor by La Starza, Roberta, Barba, Gianluca, Nofrini, Valeria, Pierini, Tiziana, Pierini, Valentina, Marcomigni, Luca, Perruccio, Katia, Matteucci, Caterina, Storlazzi, Clelia Tiziana, Daniele, Giulia, Crescenzi, Barbara, Giansanti, Michele, Giovenali, Paolo, Cin, Paola Dal, Mecucci, Cristina

    Published in Cancer genetics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment

    CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment by Metro, Giulio, Lunardi, Gianluigi, Floridi, Piero, Pascali, Jennifer P., Marcomigni, Luca, Chiari, Rita, Ludovini, Vienna, Crinò, Lucio, Gori, Stefania

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib

    Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib by Ricciuti, Biagio, Marcomigni, Luca, Metro, Giulio, Bellezza, Guido, Caselli, Emanuele, Baglivo, Sara, Chiari, Rita

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

    Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype by Metro, Giulio, Chiari, Rita, Duranti, Simona, Siggillino, Annamaria, Fischer, Matthias J, Giannarelli, Diana, Ludovini, Vienna, Bennati, Chiara, Marcomigni, Luca, Baldi, Alice, Giansanti, Michele, Minotti, Vincenzo, Crinò, Lucio

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Targeting EGFR and ALK in NSCLC: current evidence and future perspective

    Targeting EGFR and ALK in NSCLC: current evidence and future perspective by Bennati, Chiara, Paglialunga, Luca, Ricciuti, Biagio, Metro, Giulio, Marcomigni, Luca, Gili, Alessio, Crinò, Lucio

    Published in Lung cancer management
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: